Coverage for emerging technologies - bridging regulatory approval and patient access

New England Journal of Medicine

25 November 2023 - A new pathway proposed by CMS aims to expedite access to breakthrough devices while preserving Medicare’s independent role in evidence generation.

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Market access , Device